ARCHIVES

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

In Brief: NCI Needs To Move Quicker On Funding Jot New Leads, Rauscher Says; Harley Dirks Quits

October 15, 1976

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975